World News
-
New stem cell research has identified novel therapeutic targets for MS treatment
World | News | 0 Comment | 20 Dec, 2018
The preclinical findings published in Cell Reports reveal that activation of a specific transcription factor induces a phenomenon called pathological quiescence — when adult stem cell...Read more
-
Gilead Sciences and Scholar Rock announce strategic collaboration
World | News | 0 Comment | 20 Dec, 2018
Gilead Sciences and Scholar Rock Holding Corporation have announced that the companies have entered into a strategic collaboration to discover and develop highly specific inhibitors of...Read more
-
Bayer gets EU nod for Jivi, but to compete ahead: GlobalData
World | News | 0 Comment | 20 Dec, 2018
Pharma major, Bayer has recently received the European Commission approval for its hemophilia A long-acting injectable medicine Jivi. However, since Jivi is a late entrant to the long-actin...Read more
-
World | News | 0 Comment | 20 Dec, 2018
Gritstone Oncology, Inc., a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types has announced that data demonstratin...Read more
-
Smith to acquire Ceterix for up to $105M
World | News | 0 Comment | 19 Dec, 2018
Singapore - Smith & Nephew announces that it has agreed to acquire Ceterix Orthopaedics and its NovoStitch Pro knee repair device. The deal calls for the British orthop...Read more
-
Amgen, Molecular Partners team up for Immuno-Oncology
World | News | 0 Comment | 19 Dec, 2018
Amgen and Molecular Partners, a clinical-stage biotech company pioneering the use of DARPin® therapeutics, have announced a collaboration and license agreement for the clinical dev...Read more
-
Erasca completes $42M series A financing round
World | News | 0 Comment | 19 Dec, 2018
Erasca, a company dedicated to advancing exceptional scientific approaches to erase cancer, has completed a $42 million Series A financing round co-led by founding investors City Hill Ventu...Read more
-
Lexicon Pharma announces positive topline clinical data for LX9211
World | News | 0 Comment | 19 Dec, 2018
Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211, a potent oral small molecule inhibitor of adaptor associated kinase...Read more
-
DelSiTech, Innovare sign licensing agrrement for the development of a long acting HIV Therapy
World | News | 0 Comment | 19 Dec, 2018
DelSiTech Ltd, a Finnish drug delivery technology and drug development company and InnovareR&D, a leading Mexican pharmaceutical company, have signed a world-wide, exclusive licence agr...Read more
-
IFM Therapeutics announces discovery of new immune system triggers
World | News | 0 Comment | 19 Dec, 2018
IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system has announced the discovery of new...Read more
-
Staten Biotechnology, Novo Nordisk enter into a deal worth $430M
World | News | 0 Comment | 18 Dec, 2018
Staten Biotechnology has signed a dyslipidaemia licence option deal worth US$430 million with Novo Nordisk. Under the agreement, Dutch Staten Biotechnology B.V. and Novo Nordis...Read more
-
Global Cannabis Partnership expands to 31 members
World | News | 0 Comment | 18 Dec, 2018
The Global Cannabis Partnership (GCP) is pleased to announce the addition of seven new Members as it continues to grow internationally, bringing its total membership number to 31. The GCP ...Read more
-
Orchard Therapeutics, SIRION Biotech partners for gene therapy
World | News | 0 Comment | 18 Dec, 2018
Orchard Therapeutics, a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative...Read more
-
Bristol-Myers Squibb receives positive CHMP Opinion recommending Sprycel for Pediatric Patients
World | News | 0 Comment | 18 Dec, 2018
Bristol-Myers Squibb Company has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the expanded approval of Sprycel (...Read more
-
Bristol-Myers Squibb, Boston Medical Centre announce collaboration
World | News | 0 Comment | 18 Dec, 2018
Bristol-Myers Squibb Company and Boston Medical centre, a private, not-for-profit, academic medical centre has announced a multi-year joint research study to identify and analyze potential ...Read more
-
Merck launches new Steritest NEO Device
World | News | 0 Comment | 18 Dec, 2018
Merck has launched the latest evolution in sterility testing devices, the Steritest™ NEO device, which provides safer pharmaceutical product testing, with greater reliability and conv...Read more
-
Lilly to acquire Pre-Clinical Pain Program from Hydra Biosciences
World | News | 0 Comment | 17 Dec, 2018
Eli Lilly and Company has announced an agreement with Hydra Biosciences to acquire all assets related to Hydra's pre-clinical program of TRPA1 antagonists which is a part of the Transient R...Read more
-
Lilly announces positive top-line results for Taltz
World | News | 0 Comment | 17 Dec, 2018
Eli Lilly and Company has announced that Taltz® (ixekizumab) met the primary and all major secondary endpoints in the Phase 3b/4 SPIRIT-H2H study, which evaluated the efficacy...Read more
